OHSU Knight Cancer Institute clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 243 studies whose lead sponsor is OHSU Knight Cancer Institute. 44 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the OHSU Knight Cancer Institute studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions OHSU Knight Cancer Institute leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 243. Browse all 243 →
- Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal TherapyRecruitingNCT05919329Phase 4
- Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaRecruitingNCT07228273Phase 2
- EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
- Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet DisorderRecruitingNCT07844694Phase 1
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaRecruitingNCT07089940Early Phase 1
- Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationRecruitingNCT07548983Phase 1
- Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck CancersRecruitingNCT07857655Phase 4
- Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T TreatmentRecruitingNCT06784167
- Feasibility of FMISO in Brain TumorsRecruitingNCT03649880Phase 2
- Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerRecruitingNCT05081024
- Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLRecruitingNCT06504459Phase 2
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingNCT03270059Phase 2
- Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With CancerRecruitingNCT06562777
- Targeted Pathway Inhibition in Patients With Pancreatic CancerRecruitingNCT04005690Early Phase 1
- Mammogram Pretreatment With Ulipristal AcetateRecruitingNCT07434128Phase 2
- Use Of Indocyanine Green In Pancreas SurgeryRecruitingNCT06084013
- Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRTRecruitingNCT07498517Phase 2
- An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO TrialRecruitingNCT07278440Not applicable
- CREATE: Art for Children With CancerRecruitingNCT06342453Not applicable
- Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER TrialRecruitingNCT07726602
- Pathogenesis of Hematologic MalignanciesEnrolling by invitationNCT01728402
- Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other DisordersAvailableNCT03626285
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
- Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer TrialNot yet recruitingNCT07664241Not applicable
- Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT04659616Phase 1
- Identifying and Caring for Individuals With Inherited Cancer SyndromeRecruitingNCT04494945Not applicable
- Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06320405Phase 1/2
- Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell LymphomaRecruitingNCT06249191Phase 1/2
- Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid LeukemiaRecruitingNCT06357182Phase 1
- Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity SyndromeRecruitingNCT06895473Phase 2
- Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint InhibitorNot yet recruitingNCT07660666Not applicable
- A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant ChemotherapyRecruitingNCT07651358Not applicable
- 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerRecruitingNCT04529044Phase 2
- Phase I Randomized Controlled Trial of Functional Resistance Training in Older Cancer Survivors: The ACES TrialNot yet recruitingNCT07606313Not applicable
- Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal CancerRecruitingNCT06067438Phase 2
- Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVERecruitingNCT06011499Not applicable
- GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate CancerRecruitingNCT07504835Not applicable
- Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular CarcinomaNot yet recruitingNCT07511504Phase 2
- MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and ReferralsEnrolling by invitationNCT04996316
- Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL TrialRecruitingNCT06357676Phase 1/2
- Impact of Dietary Fiber Supplementation on Colonic MicrobiomeRecruitingNCT05643859Not applicable
- A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic TumorsNot yet recruitingNCT05453851Phase 1/2
- Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaRecruitingNCT05943496Phase 1
- Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking CessationCompletedNCT04969978Not applicable
- Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN TrialSuspendedNCT06673095Not applicable
- Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53 Mutated Acute Myeloid LeukemiaActive, not recruitingNCT05396859Phase 1
- Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral NeuropathyCompletedNCT04170075Not applicable
- Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyActive, not recruitingNCT04993313Not applicable
- Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT02522715Phase 1/2